Korean investigators reported that faricimab (Vabysmo, Roche/Genentech) in a real-world setting works well for patients with neovascular age-related macular degeneration (nAMD) refractory to other ...

Panelists discuss how the potential availability of tyrosine kinase inhibitors (TKIs) could diminish some advantages of the PDS system, as oral medications would provide an alternative approach to ...

4D Molecular Therapeutics announced it will present the initial interim 52-week data from the Phase 2b Population Extension cohort of the PRISM clinical trial. The trial is evaluating 4D-150 in a ...

EYLEA’s unique MoA: What is the rationale for the higher molar dose?

Ashkan Abbey, MD, shares insights from the one-year data for the phase 2 DAVIO2 trial and the impact of tyrosine kinase inhibitors on reducing treatment burden. Basically, we were looking at the ...

A new study 1 from Turkey reported that during the acute phase of the COVID-19 infection, the retinal vascularity and perfusion of the retina decreases and the foveal avascular zone (FAZ) expands. The ...

The company offers year-round educational services on the conditions, using this month in particular to guide patients to ...